Strengthening Partnerships: Tajikistan Health Ministry and Health Insurance Organization Unite for Enhanced Healthcare

Strengthening Partnerships: Tajikistan Health Ministry and Health Insurance Organization Unite for Enhanced Healthcare

In a significant development, the Iranian Health Insurance Organization’s head, Mohammad-Mehdi Nasehi, and Tajikistan’s Minister of Health and Social Protection, Jamoliddin Abdullozoda, have taken steps to enhance collaboration in the area of medical health insurance. Their recent meeting in Tajikistan highlighted opportunities for joint investments aimed at improving health services in both nations.

Nasehi expressed the Iranian organization’s commitment to sharing valuable experiences with Tajikistan, a move intended to fortify the latter’s insurance framework. This partnership aims to create a more robust health insurance system that could potentially benefit both countries.

Expansion of Health Insurance Services

In 2024, the Iranian health insurance sector made notable advancements by adding seven new anti-cancer medications to its rare diseases fund. This expansion means that the health insurance will now cover 70 percent of the costs associated with these treatments. According to IRIB, Mohammad-Esmaeil Kameli, a representative from the health insurance organization, stated:

“Currently, with the inclusion of these seven drugs, a total of 90 anti-cancer drugs are covered by the rare and hard-to-treat diseases fund, and the health insurance is paying 70 to 95 percent of their costs.”

Growth in Health Centers Collaborating with Health Insurance

Further emphasizing the growth in the health insurance sector, the number of health centers that have entered contracts with the Health Insurance Organization witnessed a remarkable increase of seven percent during the last Iranian calendar year, which concluded on March 19. As reported by IRNA, Keivan Tajbakhsh, an official from the organization, shared:

  • More than 53,000 centers have signed contracts with health insurance organizations this year.
  • These contracts encompass a variety of services from government, non-government, private, and charity health centers.
  • The types of centers involved include doctors’ offices, hospitals, pharmacies, rehabilitation facilities, and all medical centers.

Tajbakhsh added, “We hope to witness an increase in the number of health centers that are parties to the contract with Health Insurance Organization as new forms of the contract, approved by the Supreme Council of Insurance, are announced.”

Breakdown of Health Insurance Contracts

In an impressive breakdown of the contracted health centers, the following figures highlight the breadth of the network:

  • 13,931 pharmacies
  • 20,804 doctors’ offices
  • 2,049 clinics
  • 2,446 independent laboratories
  • 4,261 rehabilitation centers, both independent and affiliated with other organizations

National Cancer Control Program

With the backing of the World Health Organization, Iran has developed a comprehensive national cancer control program, which outlines the Ministry of Health’s strategic plan extending to the Iranian calendar year 1404 (March 2025 – March 2026). The primary goals of this initiative include:

  • Reducing cancer prevalence and mortality rates.
  • Enhancing the quality of life for patients.
  • Developing a model that can be replicated in other countries, particularly in the Eastern Mediterranean region.

This program focuses on two critical documents: the “development of a national cancer care network” and the “development of cancer human resources.” These efforts have led to the establishment of early diagnostic centers, which are crucial for timely intervention and treatment.

Significant Services Provided by the Health Insurance Organization

The Health Insurance Organization, in collaboration with the Ministry of Health, has delivered essential services across various sectors. Some of the key services include:

  • Providing free insurance for low-income families.
  • Covering medical expenses for infertile couples.
  • Offering support services to individuals with disabilities.
  • Aiding patients with rare diseases.
  • Extending health services to foreign nationals.

This robust support system illustrates the Iranian Health Insurance Organization’s commitment to enhancing health care accessibility and quality for all citizens, while also fostering valuable international partnerships.

As these initiatives unfold, it is anticipated that both Iran and Tajikistan will benefit from enhanced health insurance frameworks, ultimately leading to better health outcomes for their populations.

Similar Posts

  • Iran and Russia Forge Groundbreaking MOU on Cell and Gene Therapy Collaboration

    Tehran University of Medical Sciences and the Russian Federation’s Hematological Research Center have signed a memorandum of understanding (MOU) to boost collaboration in cell and gene therapy research. The agreement, signed in Moscow, aims to enhance medical knowledge and foster science diplomacy between Iran and Russia. Key figures, including Iranian and Russian ministers, attended the ceremony during the 18th Iran-Russia Joint Economic Committee meeting. The partnership includes establishing a permanent joint committee, facilitating educational exchanges, and focusing on health sector improvements. This collaboration is expected to significantly advance healthcare and scientific research in both nations.

  • This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly.

  • Minister Calls on WHO to Safeguard Global Health Amid Sanctions Crisis

    Iran’s Health Minister, Mohammad-Reza Zafarqandi, addressed the detrimental impact of sanctions on public health during the WHO Regional Committee for the Eastern Mediterranean (RC72) in Cairo. He described sanctions as “silent wars” that undermine health systems, urging WHO members to protect healthcare from political pressures. Zafarqandi highlighted the challenges Iran faces, worsened by sanctions and conflict, emphasizing the need for regional solidarity to address health crises and climate change. He reaffirmed Iran’s commitment to enhancing healthcare, advocating for collaboration with countries like Saudi Arabia and Egypt to improve health outcomes, particularly in medication manufacturing.

  • Over 1,140 Iranians Join Elite Ranks of World’s Top 1% Most-Cited Researchers

    In 2025, Iran’s academic community achieved a milestone with 1,142 researchers recognized among the top one percent of most-cited researchers, up from 1,056 in 2024, according to the Islamic World Science Citation Institute. The Ministry of Health leads with 603 entries, while the Ministry of Science follows with 427. Key fields include Clinical Medicine, Engineering, and Pharmacology. Additionally, Stanford University identified 2,772 Iranian researchers among the top two percent based on career-long impact. This growth reflects a significant improvement in Iran’s scientific production quality, with 2,533 highly cited researchers recorded in the 2025-2026 period.

  • FAO Expert Visits Iran to Enhance Global Competitiveness of Pistachio Industry

    The Food and Agriculture Organization (FAO) has dispatched a technical delegation to Kerman Province, Iran, to enhance Iranian pistachio export standards. This three-day mission, in collaboration with Iran’s Ministry of Agriculture, focuses on improving sampling and laboratory testing for contaminants like aflatoxins, aligning with EU food safety regulations. The delegation assessed facilities, conducted workshops for local stakeholders, and emphasized best practices in sampling, pest management, and quality control. This initiative aims to strengthen regulatory compliance, improve laboratory capacities, and ensure high-quality pistachios for export, thus boosting Iran’s competitiveness in the global market.

  • Leading Knowledge-Based Companies Set to Showcase Innovations at EXPO MED 2025

    Iranian knowledge-based firms will showcase their healthcare solutions at EXPO MED 2025, taking place from April 24 to 26 in Istanbul, Turkey. This pivotal event is expected to attract over 35,000 visitors from 120 countries and will highlight advancements across various medical sectors, including electromedical equipment and wellness solutions. Iranian Health Minister Mohammad-Reza Zafarqandi emphasized the government’s goal of achieving self-sufficiency in medical production, with over 70% of medical equipment used domestically manufactured in Iran. The exhibition aims to strengthen international collaborations and showcase Iran’s capabilities in the healthcare industry, reinforcing its global presence.